Cyclopentane for synthesis

Hazard statements (CLP)

H225, H304, H336, H412

Code

Statements

H225

Highly Flammable liquid and vapour

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Flammable liquids, (Category 2) H225: Highly flammable liquid and vapor. Specific target organ toxicity - H336: May cause drowsiness or dizziness. single exposure, (Category 3), Central nervous system Aspiration hazard, (Category 1) H304: May be fatal if swallowed and enters airways. Long-term (chronic) aquatic H412: Harmful to aquatic life with long hazard, (Category 3) lasting effects.

Aspiration hazard

(Category 1) H304 May be fatal if swallowed and enters airways. Long-term (chronic) aquatic H412: Harmful to aquatic life with long hazard, (Category 3) lasting effects.

Signal word

Danger Danger

Hazard statements

H225 Highly flammable liquid and vapor. H304 May be fatal if swallowed and enters airways. H336 May cause drowsiness or dizziness. H412 Harmful to aquatic life with long lasting effects. H304 May be fatal if swallowed and enters airways. H412 Harmful to aquatic life with long lasting effects.

Precautionary statements

P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 Keep container tightly closed. P240 Ground and bond container and receiving equipment. P273 Avoid release to the environment. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P331 Do NOT induce vomiting. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P331 Do NOT induce vomiting.

Supplemental label elements

EUH066 Repeated exposure may cause skin dryness or cracking. Contains microplastic. Do not release into the environment. Reduced Labeling (<= 125 ml) EUH066 Repeated exposure may cause skin dryness or cracking.

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.